Advertisement
Screener

NEXGEL, INC. (NXGL) Form D

NEXGEL, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-08-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-07-30; Total offering amount $500,000.
  • 2019-09-25: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-09-10; Total offering amount $750,000.
  • 2009-08-28: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2009-08-26; Total offering amount $1,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-08-21Rule 506(b)Equity2020-07-30$500,000$395,100$104,9005
2019-09-25Rule 506(b)Equity2019-09-10$750,000$175,000$575,0002
2009-08-28Rule 506Equity2009-08-26$1,000,000$415,590$584,4106

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Profusa, Inc. (PFSA)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B